{
  "abstract": "Chimeric antigen receptor (CAR) T-cell therapy has transformed the treatment of B-cell malignancies, but relapse after CD19-directed therapy remains a major challenge, often because of loss or downregulation of CD19 expression. CD22 is an attractive alternative target because it is expressed on malignant B cells, including in many cases of CD19-negative disease. In this study, we generated and characterized novel anti-CD22 monoclonal antibody–derived CAR constructs for in vitro evaluation. Four anti-CD22 monoclonal antibody clones were initially screened, and two clones, 24A7G6 and 29H9C8, were selected for CAR development based on their favorable binding and CAR surface expression profiles. Second-generation CAR constructs containing either a 4−1BB or CD28 costimulatory domain were generated and introduced into primary human T cells. The resulting CAR T cells were evaluated for expansion, immunophenotype, activation and inhibitory marker expression, cytokine secretion, short-term cytotoxicity, long-term co-culture activity, and sequential tumor rechallenge against CD22-positive Raji and Nalm-6 cells and CD22-negative K562 cells. Both 24A7G6- and 29H9C8-derived CAR T cells expanded efficiently, showed predominant CD8 + populations with naïve and central memory phenotypes, and mediated potent antigen-specific cytotoxicity against CD22-positive target cells, while showing no activity against CD22-negative cells. Following antigen stimulation, CAR T cells upregulated activation markers and showed modest increases in inhibitory receptors. In long-term co-culture and sequential rechallenge assays, all constructs retained antitumor activity under prolonged antigen exposure. Notably, the 24A7G6-CD28 CAR demonstrated enhanced sustained tumor control compared with the corresponding 4−1BB construct in extended assays, whereas short-term cytotoxicity was broadly comparable across constructs. These findings show that the newly generated 24A7G6 and 29H9C8 scFvs can function as effective targeting domains for CD22-directed CAR T-cell development and provide an in vitro basis for prioritizing lead constructs for further preclinical evaluation.",
  "abstract_shown": true,
  "affiliations": [
    "Faculty of Pharmaceutical Science, MSc Program in Research for Enterprise, Chulalongkorn University, Bangkok, Thailand",
    "Center of Excellence in Cellular Immunotherapy, Chulalongkorn University, Bangkok, Thailand",
    "Cell and Gene Therapy Manufacturing Center, King Chulalongkorn Memorial Hospital, Bangkok, Thailand",
    "Faculty of Medicine, Center of Excellence in Systems Biology, Chulalongkorn University, Bangkok, Thailand",
    "Thailand Hub of Talents in Cancer Immunotherapy, Bangkok, Thailand",
    "Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand",
    "Department of Research Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand"
  ],
  "article_type": "Research Article",
  "arxiv": null,
  "author_total": 8,
  "authors": [
    {
      "affs": [
        0,
        1
      ],
      "name": "Wipawadee Ruengdej"
    },
    {
      "affs": [
        1,
        2
      ],
      "name": "Vichaya Chuthaphakdikun",
      "orcid": "0009-0004-1250-2961"
    },
    {
      "affs": [
        1
      ],
      "name": "Sirirut Jewmoung"
    },
    {
      "affs": [
        1
      ],
      "name": "Nithidol Sakunrangsit",
      "orcid": "0000-0002-1759-5974"
    },
    {
      "affs": [
        3
      ],
      "name": "Chatikorn Boonkrai"
    },
    {
      "affs": [
        3
      ],
      "name": "Trairak Pisitkun"
    },
    {
      "affs": [
        1,
        2,
        4,
        5
      ],
      "name": "Supannikar Tawinwung",
      "orcid": "0000-0003-2151-4580"
    },
    {
      "affs": [
        1,
        2,
        4,
        6
      ],
      "name": "Koramit Suppipat",
      "orcid": "0000-0002-4010-933X"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/dvx7x6av2pqzw.bib",
  "cited_by": 0,
  "doi": "10.1371/journal.pone.0362221",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13759115/",
  "id": "dvx7x6av2pqzw",
  "issns": [
    "1932-6203"
  ],
  "landing_url": "https://doi.org/10.1371/journal.pone.0362221",
  "language": "en",
  "licence": "CC-BY-4.0",
  "licence_label": "CC BY 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Antibodies"
    ],
    [
      "heading",
      "Biochemistry"
    ],
    [
      "heading",
      "Biological Cultures"
    ],
    [
      "heading",
      "Biology and Life Sciences"
    ],
    [
      "heading",
      "Cancer Immunotherapy"
    ],
    [
      "heading",
      "Cancer Treatment"
    ],
    [
      "heading",
      "Cell Lines"
    ],
    [
      "heading",
      "Clinical Immunology"
    ],
    [
      "heading",
      "Clinical Medicine"
    ],
    [
      "heading",
      "Cloning"
    ],
    [
      "heading",
      "Cytokines"
    ],
    [
      "heading",
      "Cytophotometry"
    ],
    [
      "heading",
      "Cytotoxicity"
    ],
    [
      "heading",
      "Cytotoxicity Assay"
    ],
    [
      "heading",
      "Developmental Biology"
    ],
    [
      "heading",
      "Flow Cytometry"
    ],
    [
      "heading",
      "Immune Physiology"
    ],
    [
      "heading",
      "Immune System"
    ],
    [
      "heading",
      "Immune System Proteins"
    ],
    [
      "heading",
      "Immunology"
    ],
    [
      "heading",
      "Immunotherapy"
    ],
    [
      "heading",
      "Innate Immune System"
    ],
    [
      "heading",
      "Medicine and Health Sciences"
    ],
    [
      "heading",
      "Molecular Biology"
    ],
    [
      "heading",
      "Molecular Biology Techniques"
    ],
    [
      "heading",
      "Molecular Development"
    ],
    [
      "heading",
      "Monoclonal Antibodies"
    ],
    [
      "heading",
      "Oncology"
    ],
    [
      "heading",
      "Pathology and Laboratory Medicine"
    ],
    [
      "heading",
      "Physiology"
    ],
    [
      "heading",
      "Proteins"
    ],
    [
      "heading",
      "Raji Cells"
    ],
    [
      "heading",
      "Research Article"
    ],
    [
      "heading",
      "Research and Analysis Methods"
    ],
    [
      "heading",
      "Spectrophotometry"
    ],
    [
      "heading",
      "Spectrum Analysis Techniques"
    ],
    [
      "heading",
      "Toxicology"
    ],
    [
      "plos",
      "/Biology and life sciences/Biochemistry/Proteins/Immune system proteins/Antibodies/Monoclonal antibodies"
    ],
    [
      "plos",
      "/Biology and life sciences/Developmental biology/Molecular development/Cytokines"
    ],
    [
      "plos",
      "/Biology and life sciences/Immunology/Clinical immunology/Immunotherapy/Cancer immunotherapy"
    ],
    [
      "plos",
      "/Biology and life sciences/Immunology/Immune system proteins/Antibodies/Monoclonal antibodies"
    ],
    [
      "plos",
      "/Biology and life sciences/Immunology/Immune system/Innate immune system/Cytokines"
    ],
    [
      "plos",
      "/Biology and life sciences/Molecular biology/Molecular biology techniques/Cloning"
    ],
    [
      "plos",
      "/Biology and life sciences/Physiology/Immune physiology/Antibodies/Monoclonal antibodies"
    ],
    [
      "plos",
      "/Biology and life sciences/Physiology/Immune physiology/Cytokines"
    ],
    [
      "plos",
      "/Biology and life sciences/Toxicology/Cytotoxicity"
    ],
    [
      "plos",
      "/Biology and life sciences/Toxicology/Cytotoxicity assay"
    ],
    [
      "plos",
      "/Medicine and health sciences/Clinical medicine/Clinical immunology/Immunotherapy/Cancer immunotherapy"
    ],
    [
      "plos",
      "/Medicine and health sciences/Immunology/Clinical immunology/Immunotherapy/Cancer immunotherapy"
    ],
    [
      "plos",
      "/Medicine and health sciences/Immunology/Immune system proteins/Antibodies/Monoclonal antibodies"
    ],
    [
      "plos",
      "/Medicine and health sciences/Immunology/Immune system/Innate immune system/Cytokines"
    ],
    [
      "plos",
      "/Medicine and health sciences/Oncology/Cancer treatment/Cancer immunotherapy"
    ],
    [
      "plos",
      "/Medicine and health sciences/Pathology and laboratory medicine/Toxicology/Cytotoxicity"
    ],
    [
      "plos",
      "/Medicine and health sciences/Pathology and laboratory medicine/Toxicology/Cytotoxicity assay"
    ],
    [
      "plos",
      "/Research and analysis methods/Biological cultures/Cell lines/Raji cells"
    ],
    [
      "plos",
      "/Research and analysis methods/Molecular biology techniques/Cloning"
    ],
    [
      "plos",
      "/Research and analysis methods/Spectrum analysis techniques/Spectrophotometry/Cytophotometry/Flow cytometry"
    ]
  ],
  "openalex": null,
  "pdf_url": null,
  "pmcid": "PMC13759115",
  "pmid": "43019359",
  "published": "2026-11-12",
  "publisher": "Public Library of Science",
  "ris": "https://research.draconitic.com/paper/dvx7x6av2pqzw.ris",
  "sources": [
    {
      "first_seen": "2026-11-13T12:20:02Z",
      "native_id": "10.1371/journal.pone.0362221",
      "source": "plos",
      "url": "https://doi.org/10.1371/journal.pone.0362221"
    },
    {
      "first_seen": "2026-11-16T12:23:44Z",
      "native_id": "PMC13759115",
      "source": "pmc",
      "url": "https://doi.org/10.1371/journal.pone.0362221"
    }
  ],
  "subjects": [
    {
      "field": "biochemistry",
      "origin": "heading:Molecular Biology",
      "subfield": "molecular-biology"
    },
    {
      "field": "biology",
      "origin": "heading:Developmental Biology",
      "subfield": "developmental-biology"
    },
    {
      "field": "biology",
      "origin": "plos:immunology",
      "subfield": "immunology"
    },
    {
      "field": "medicine",
      "origin": "heading:Oncology",
      "subfield": "oncology"
    },
    {
      "field": "medicine",
      "origin": "plos:toxicology",
      "subfield": "pharmacology-toxicology"
    }
  ],
  "title": "Generation and in vitro functional characterization of anti-CD22 chimeric antigen receptor T cells derived from newly generated monoclonal antibody clones",
  "title_text": "Generation and in vitro functional characterization of anti-CD22 chimeric antigen receptor T cells derived from newly generated monoclonal antibody clones",
  "type": "peer-reviewed",
  "updated_at": "2026-11-16T12:23:44Z",
  "url": "https://research.draconitic.com/paper/dvx7x6av2pqzw",
  "venue": "PLOS One",
  "versions": []
}